Related Experiment Video
Updated: Jul 4, 2025
![Quantitative [18F]-Naf-PET-MRI Analysis for the Evaluation of Dynamic Bone Turnover in a Patient with Facetogenic Low Back Pain](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F58491.jpg&w=3840&q=50)
Quantitative [18F]-Naf-PET-MRI Analysis for the Evaluation of Dynamic Bone Turnover in a Patient with Facetogenic Low Back Pain
Published on: August 8, 2019
Beyond Anatomy: Fat-Suppressed MR and Molecular Imaging of Spinal Pain Generators
Vance T Lehman1, Christin A Tiegs-Heiden1, Stephen M Broski1
1Department of Radiology, Mayo Clinic, 200 1st Street SouthWest, Rochester, MN 55905, USA.
Abstract:
Spine pain is highly prevalent and costly, but evaluation with clinical features and anatomic imaging remain limited. Fat-suppressed MR imaging and molecular imaging (MI) may help identify inflammatory, lesional, and malignant causes. Numerous MI agents are available, each with advantages and disadvantages. Herein, FDG PET, prostate-specific membrane antigen (PSMA), bone radiotracers, and others are highlighted. No specific pain MI agents have been identified, but mechanisms of key agents are shown in video format, and the mechanism of PSMA as a theranostic agent is displayed. A multidisciplinary approach is needed to master this topic.
Insights
Molecular imaging (MI) offers advanced insights into spine pain causes beyond traditional methods. While no specific pain MI agents exist, techniques like FDG PET and PSMA show promise in identifying inflammatory, lesional, and malignant conditions.
Area of Science:
- Radiology
- Nuclear Medicine
- Oncology
Background:
- Spine pain is a widespread and expensive health issue.
- Current diagnostic methods, including clinical evaluation and anatomical imaging, have limitations in identifying underlying causes.
- Inflammatory, lesional, and malignant etiologies of spine pain require advanced diagnostic tools.
Purpose of the Study:
- To review the role of molecular imaging (MI) in evaluating spine pain.
- To highlight various MI agents and their mechanisms for diagnosing spine pathologies.
- To discuss the potential of MI in identifying specific causes of spine pain.
Main Methods:
- Review of available molecular imaging agents for spine evaluation.
- Discussion of fat-suppressed MR imaging and specific MI techniques (FDG PET, PSMA, bone radiotracers).
- Inclusion of video demonstrations for agent mechanisms and PSMA's theranostic application.
Main Results:
- Molecular imaging, including FDG PET and PSMA, can identify inflammatory, lesional, and malignant causes of spine pain.
- No specific MI agents exclusively for pain have been identified.
- The mechanism of PSMA as a theranostic agent is presented.
Conclusions:
- Molecular imaging provides valuable complementary information for diagnosing complex spine pain.
- A multidisciplinary approach is essential for effectively utilizing MI in spine pain management.
- Further research may identify novel MI agents or refine existing ones for pain evaluation.
